Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 10 | 2015 | 64 | 2.260 |
Why?
|
| Laparoscopy | 14 | 2021 | 302 | 1.970 |
Why?
|
| Hernia, Hiatal | 2 | 2021 | 21 | 1.370 |
Why?
|
| Obesity, Morbid | 5 | 2015 | 79 | 1.330 |
Why?
|
| Insulin Resistance | 7 | 2015 | 373 | 0.900 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 53 | 0.720 |
Why?
|
| Blood Glucose | 2 | 2015 | 441 | 0.530 |
Why?
|
| Preoperative Care | 1 | 2015 | 141 | 0.510 |
Why?
|
| Weight Loss | 5 | 2015 | 267 | 0.480 |
Why?
|
| Obesity | 5 | 2015 | 1125 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 5 | 2001 | 277 | 0.420 |
Why?
|
| Insulin | 3 | 2011 | 658 | 0.390 |
Why?
|
| Heart Conduction System | 1 | 2009 | 31 | 0.380 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2007 | 41 | 0.380 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 36 | 0.370 |
Why?
|
| Heart Rate | 1 | 2009 | 263 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 604 | 0.340 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 22 | 0.320 |
Why?
|
| Adipose Tissue, Brown | 1 | 2007 | 70 | 0.300 |
Why?
|
| Postoperative Complications | 3 | 2015 | 881 | 0.300 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 500 | 0.290 |
Why?
|
| Glucose | 2 | 2007 | 371 | 0.280 |
Why?
|
| Homeostasis | 1 | 2007 | 307 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2021 | 4513 | 0.250 |
Why?
|
| Incidence | 2 | 2021 | 1121 | 0.240 |
Why?
|
| Humans | 27 | 2021 | 49598 | 0.240 |
Why?
|
| Adult | 13 | 2015 | 13325 | 0.230 |
Why?
|
| Male | 18 | 2015 | 23121 | 0.220 |
Why?
|
| Middle Aged | 14 | 2015 | 13448 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 165 | 0.210 |
Why?
|
| Surgical Mesh | 1 | 2021 | 49 | 0.210 |
Why?
|
| Esophagectomy | 1 | 2021 | 34 | 0.210 |
Why?
|
| Female | 17 | 2015 | 26314 | 0.210 |
Why?
|
| Recurrence | 2 | 2021 | 496 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2001 | 157 | 0.200 |
Why?
|
| Kupffer Cells | 2 | 2015 | 40 | 0.190 |
Why?
|
| Body Mass Index | 5 | 2011 | 852 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 1936 | 0.180 |
Why?
|
| Aspirin | 1 | 2000 | 167 | 0.170 |
Why?
|
| Risk Factors | 2 | 2021 | 4246 | 0.160 |
Why?
|
| Adipose Tissue, White | 2 | 2008 | 69 | 0.160 |
Why?
|
| Adipose Tissue | 2 | 2010 | 288 | 0.150 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 45 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 73 | 0.130 |
Why?
|
| Remission Induction | 1 | 2015 | 126 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2011 | 3887 | 0.130 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 39 | 0.130 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 64 | 0.130 |
Why?
|
| Splenectomy | 2 | 2004 | 35 | 0.130 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 71 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 415 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2001 | 329 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 552 | 0.110 |
Why?
|
| Prognosis | 1 | 2015 | 1250 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 31 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 43 | 0.100 |
Why?
|
| Omentum | 1 | 2010 | 13 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 398 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 175 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 118 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 102 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 21 | 0.100 |
Why?
|
| Sodium Salicylate | 2 | 1999 | 2 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 821 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 170 | 0.090 |
Why?
|
| Sex Factors | 2 | 2009 | 851 | 0.090 |
Why?
|
| Hernia | 1 | 2009 | 11 | 0.090 |
Why?
|
| I-kappa B Proteins | 2 | 1999 | 30 | 0.090 |
Why?
|
| Peritoneal Lavage | 1 | 2009 | 3 | 0.090 |
Why?
|
| Colon, Sigmoid | 1 | 2009 | 6 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2000 | 428 | 0.090 |
Why?
|
| Diverticulitis | 1 | 2009 | 21 | 0.090 |
Why?
|
| Gastroplasty | 1 | 2008 | 13 | 0.090 |
Why?
|
| Linear Models | 1 | 2009 | 409 | 0.090 |
Why?
|
| Wounds, Stab | 1 | 2008 | 9 | 0.090 |
Why?
|
| Radiography | 1 | 2009 | 341 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2008 | 20 | 0.080 |
Why?
|
| Age Factors | 2 | 2009 | 1410 | 0.080 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 31 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 138 | 0.080 |
Why?
|
| Immunoassay | 1 | 2007 | 57 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 56 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 87 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2000 | 534 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 239 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 580 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2007 | 148 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 66 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2006 | 54 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 1000 | 0.070 |
Why?
|
| Contrast Media | 1 | 2007 | 293 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 750 | 0.070 |
Why?
|
| Splenomegaly | 1 | 2004 | 22 | 0.070 |
Why?
|
| Splenic Diseases | 1 | 2004 | 13 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 431 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 523 | 0.070 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2004 | 23 | 0.070 |
Why?
|
| Inflammation | 1 | 2010 | 978 | 0.060 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2003 | 4 | 0.060 |
Why?
|
| Apoptosis | 2 | 1999 | 979 | 0.060 |
Why?
|
| G1 Phase | 2 | 2001 | 52 | 0.060 |
Why?
|
| Adrenalectomy | 1 | 2003 | 23 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 58 | 0.060 |
Why?
|
| Macrophages | 2 | 1999 | 913 | 0.060 |
Why?
|
| S Phase | 2 | 2001 | 72 | 0.060 |
Why?
|
| Massachusetts | 1 | 2009 | 2017 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2003 | 101 | 0.060 |
Why?
|
| Cell Separation | 2 | 2000 | 137 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 1574 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2009 | 2519 | 0.060 |
Why?
|
| Spleen | 1 | 2004 | 450 | 0.060 |
Why?
|
| Immunophilins | 1 | 2001 | 1 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 7 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 44 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2001 | 636 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1049 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2008 | 661 | 0.050 |
Why?
|
| Chromones | 1 | 2000 | 15 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2000 | 109 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2000 | 20 | 0.050 |
Why?
|
| Morpholines | 1 | 2000 | 63 | 0.050 |
Why?
|
| Flavonoids | 1 | 2000 | 67 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 1376 | 0.050 |
Why?
|
| Young Adult | 1 | 2009 | 3698 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 22 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 29 | 0.050 |
Why?
|
| Ubiquitins | 1 | 1999 | 39 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2006 | 790 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 77 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 68 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1999 | 28 | 0.050 |
Why?
|
| Aged | 4 | 2009 | 10871 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 164 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2003 | 541 | 0.040 |
Why?
|
| Endotoxins | 1 | 1999 | 70 | 0.040 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 623 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 364 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2000 | 196 | 0.040 |
Why?
|
| Adipocytes | 2 | 2010 | 225 | 0.040 |
Why?
|
| Animals | 7 | 2015 | 17697 | 0.040 |
Why?
|
| Liver | 1 | 2000 | 709 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2854 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 57 | 0.030 |
Why?
|
| Peptic Ulcer | 1 | 2015 | 22 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 129 | 0.030 |
Why?
|
| Laparotomy | 2 | 2008 | 35 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2015 | 40 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 96 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 57 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 428 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2015 | 85 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 430 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 326 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 189 | 0.030 |
Why?
|
| Mice | 3 | 2015 | 9076 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 184 | 0.030 |
Why?
|
| Swine | 2 | 2006 | 294 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 354 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2006 | 275 | 0.030 |
Why?
|
| Mutation | 1 | 2000 | 2187 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1390 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 275 | 0.030 |
Why?
|
| Length of Stay | 2 | 2006 | 627 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2017 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 816 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2001 | 2681 | 0.030 |
Why?
|
| Chemokines | 1 | 2010 | 89 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 1999 | 21 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2000 | 327 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 803 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 456 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 496 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 163 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 83 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 172 | 0.020 |
Why?
|
| Lipolysis | 1 | 2008 | 38 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 177 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 48 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 67 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 753 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 202 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 59 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 361 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 1679 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 75 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 20 | 0.020 |
Why?
|
| Abdomen | 1 | 2006 | 93 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 3127 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 349 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 950 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1498 | 0.020 |
Why?
|
| Palpation | 1 | 2004 | 9 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 18 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1885 | 0.020 |
Why?
|
| Hand | 1 | 2004 | 47 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 61 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 366 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2004 | 50 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 2064 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1036 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 704 | 0.010 |
Why?
|
| Mitogens | 1 | 2001 | 9 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2001 | 10 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 750 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 27 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 32 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2000 | 11 | 0.010 |
Why?
|
| Sirolimus | 1 | 2001 | 65 | 0.010 |
Why?
|
| Bile | 1 | 2000 | 15 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 2000 | 10 | 0.010 |
Why?
|
| Reperfusion | 1 | 2000 | 26 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2001 | 106 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 47 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 129 | 0.010 |
Why?
|
| Ibuprofen | 1 | 1999 | 16 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 34 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 282 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 50 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1499 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1999 | 5 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1999 | 110 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1999 | 24 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 117 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 528 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 559 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 1920 | 0.010 |
Why?
|